Detalhe da pesquisa
1.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369901
2.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264544
3.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 23(5): 659-670, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427471
4.
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Ann Surg Oncol
; 29(4): 2456-2468, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129721
5.
Significant Vision Recovery from Filler-Induced Complete Blindness with Combined Intra-Arterial Injection of Hyaluronidase and Thrombolytic Agents.
Aesthetic Plast Surg
; 46(2): 907-911, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767060
6.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(5): 665-677, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812497
7.
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 133-141, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549264
8.
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 142, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679092
9.
Microsatellite-Instability-High Advanced Colorectal Cancer. Reply.
N Engl J Med
; 384(10): 972-973, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704948
10.
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med
; 372(26): 2509-20, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26028255
11.
Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
Ann Surg Oncol
; 25(1): 280-289, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29063299
12.
Integrating Immunotherapy Into Colorectal Cancer Care.
Oncology (Williston Park)
; 32(10): 494-8, 2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334238
13.
An Expanding Role for Immunotherapy in Colorectal Cancer.
J Natl Compr Canc Netw
; 15(3): 401-410, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275038
14.
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.
Lancet Oncol
; 17(6): 717-726, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27157491
15.
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
Lancet Oncol
; 17(11): 1590-1598, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27733243
16.
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Lancet Oncol
; 17(7): 883-895, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269741
17.
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.
Kidney Int
; 90(3): 638-47, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27282937
18.
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.
Oncologist
; 21(10): 1200-1211, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412392
19.
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
Int J Cancer
; 136(1): 127-37, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24832153
20.
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
Ann Surg Oncol
; 22(7): 2352-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564157